MassBiologics – FDA 483, Nov 19, 2019
MassBiologics, a vaccine manufacturer in Boston, MA, received an FDA Form 483 citing significant deficiencies across its operations. The observations highlight inadequate validation of aseptic and sterilization processes, insufficient control procedures for manufacturing, and a failure to thoroughly investigate discrepancies and implement timely corrective actions. Additional concerns include poor data integrity, lack of proper supplier qualification, and non-compliance with change control and complaint handling procedures.
ID · 24eda3f4-f224-42fc-9272-a6f151517450
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.